Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novel anticoagulants synthesized and tested at Aventis

Jan. 30, 2001

Merck discloses two series of thrombin inhibitors in recent patents

Jan. 29, 2001

CI-1028: a direct thrombin inhibitor with oral antithrombotic efficacy

Jan. 23, 2001

Clinical evaluation of FKK-138 following single bolus doses

Jan. 19, 2001

New oxazaheterocyle-based protease inhibitors reported by 3DP group

Jan. 17, 2001

Anti-vWF MAb prevents thrombus deposition and neointima formation in guinea pigs

Jan. 16, 2001

Potent and selective factor Xa inhibitors patented by Cor Therapeutics

Jan. 15, 2001

Nonprostanoid PGI2 agonist with antiplatelet effects and favorable PK profile

Jan. 12, 2001

Chiron sells gene therapy manufacturing facility to Cell Genesys; retains product rights

Jan. 12, 2001

Potential anticoagulants/antithrombotics under study at Yamanouchi

Jan. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...